ERBB2 and neoplasm: For example, it has been demonstrated that overexpression of the ST6GAL1 transferase, which is linked to poor prediction in many cancer types, confers resistance to trastuzumab (anti-HER2 antibody) and gefitinib (EGFR inhibitors) -mediated programmed cell death of tumor cells [111,112].